Gildess 1.5/30

Hormonal Contraception, Mild to Moderate Acne, Premenstrual Dysphoric Disorder + 6 more
Treatment
1 FDA approval
20 Active Studies for Gildess 1.5/30

What is Gildess 1.5/30

EthinylestradiolThe Generic name of this drug
Treatment SummaryEthinylestradiol was developed in 1938 by Hans Herloff Inhoffen and Walter Hohlweg at Schering. It was created to be a more effective form of estrogen when taken orally. This was achieved by adding an ethinyl group to estradiol. Ethinylestradiol is now commonly used in contraceptive pills and was approved by the FDA in 1943.
LOESTRIN Fe 1.5/30is the brand name
Gildess 1.5/30 Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
LOESTRIN Fe 1.5/30
Ethinylestradiol
1973
674

Approved as Treatment by the FDA

Ethinylestradiol, also known as LOESTRIN Fe 1.5/30, is approved by the FDA for 1 uses including Birth Control .
Birth Control
Used to treat Contraception in combination with Levonorgestrel

Effectiveness

How Gildess 1.5/30 Affects PatientsEthinylestradiol is a hormone-based drug that stops the body from releasing certain hormones that cause ovulation and thickening of the uterus lining. It lasts a long time and is taken once daily, and it is generally considered safe with few serious side effects. However, patients should be aware of the risk of blood clots.
How Gildess 1.5/30 works in the bodyEthinylestradiol is a synthetic hormone that acts like estrogen. It affects the body in many ways, including reducing bone density. When taken as a contraceptive, it prevents pregnancy by stopping ovulation, making it difficult for sperm to travel to the egg, and preventing changes in the endometrium that are necessary for a fertilized egg to attach. Ethinylestradiol also lowers luteinizing hormone levels, which reduces the blood supply to the endometrium, and increases the amount of sex hormone binding globulin.

When to interrupt dosage

The measure of Gildess 1.5/30 is contingent upon the recognized condition, including Acne Vulgaris, Hormonal Contraception and Folate supplementation therapy. The quantity of dosage depends on the method of delivery indicated in the table underneath.
Condition
Dosage
Administration
Acne Vulgaris
0.035 mg, , 0.03 mg, 0.02 mg, 17.4 mg, 0.04 mg, 0.075 mg, 0.025 mg, 0.01 mg, 0.05 mg, 0.085 mg, 0.0015 mg/hour, 0.105 mg, 0.0025 mg, 2.3 mg, 0.6 mg, 0.0035 mg/hour, 0.07 mg, 0.005 mg, 2.7 mg, 2.6 mg, 0.5 mg, 0.75 mg, 0.35 mg, 0.75 mg/[USP'U], 0.0075 mg/hour, 1.0 mg, 0.1 mg
Oral, , Kit; Tablet, coated - Oral, Tablet, Kit; Tablet, chewable - Oral, Kit, Kit - Oral, Kit; Tablet, Kit; Tablet - Oral, Patch, extended release, Tablet - Oral, Kit; Tablet, film coated, Tablet, film coated, Vaginal, Kit; Tablet, film coated - Oral, Kit; Tablet, coated, Kit; Tablet; Tablet, chewable - Oral, Ring - Vaginal, Tablet, film coated - Oral, Kit; Tablet, chewable, Kit; Tablet; Tablet, chewable, Capsule, liquid filled; Kit, Patch - Transdermal, Transdermal, Capsule, liquid filled; Kit - Oral, Patch, extended release - Transdermal, Capsule - Oral, Ring, Patch, Insert, extended release - Vaginal, Tablet, chewable - Oral, Insert, extended release, Tablet, chewable, Capsule
Menopause
0.035 mg, , 0.03 mg, 0.02 mg, 17.4 mg, 0.04 mg, 0.075 mg, 0.025 mg, 0.01 mg, 0.05 mg, 0.085 mg, 0.0015 mg/hour, 0.105 mg, 0.0025 mg, 2.3 mg, 0.6 mg, 0.0035 mg/hour, 0.07 mg, 0.005 mg, 2.7 mg, 2.6 mg, 0.5 mg, 0.75 mg, 0.35 mg, 0.75 mg/[USP'U], 0.0075 mg/hour, 1.0 mg, 0.1 mg
Oral, , Kit; Tablet, coated - Oral, Tablet, Kit; Tablet, chewable - Oral, Kit, Kit - Oral, Kit; Tablet, Kit; Tablet - Oral, Patch, extended release, Tablet - Oral, Kit; Tablet, film coated, Tablet, film coated, Vaginal, Kit; Tablet, film coated - Oral, Kit; Tablet, coated, Kit; Tablet; Tablet, chewable - Oral, Ring - Vaginal, Tablet, film coated - Oral, Kit; Tablet, chewable, Kit; Tablet; Tablet, chewable, Capsule, liquid filled; Kit, Patch - Transdermal, Transdermal, Capsule, liquid filled; Kit - Oral, Patch, extended release - Transdermal, Capsule - Oral, Ring, Patch, Insert, extended release - Vaginal, Tablet, chewable - Oral, Insert, extended release, Tablet, chewable, Capsule
Menopausal Osteoporosis
0.035 mg, , 0.03 mg, 0.02 mg, 17.4 mg, 0.04 mg, 0.075 mg, 0.025 mg, 0.01 mg, 0.05 mg, 0.085 mg, 0.0015 mg/hour, 0.105 mg, 0.0025 mg, 2.3 mg, 0.6 mg, 0.0035 mg/hour, 0.07 mg, 0.005 mg, 2.7 mg, 2.6 mg, 0.5 mg, 0.75 mg, 0.35 mg, 0.75 mg/[USP'U], 0.0075 mg/hour, 1.0 mg, 0.1 mg
Oral, , Kit; Tablet, coated - Oral, Tablet, Kit; Tablet, chewable - Oral, Kit, Kit - Oral, Kit; Tablet, Kit; Tablet - Oral, Patch, extended release, Tablet - Oral, Kit; Tablet, film coated, Tablet, film coated, Vaginal, Kit; Tablet, film coated - Oral, Kit; Tablet, coated, Kit; Tablet; Tablet, chewable - Oral, Ring - Vaginal, Tablet, film coated - Oral, Kit; Tablet, chewable, Kit; Tablet; Tablet, chewable, Capsule, liquid filled; Kit, Patch - Transdermal, Transdermal, Capsule, liquid filled; Kit - Oral, Patch, extended release - Transdermal, Capsule - Oral, Ring, Patch, Insert, extended release - Vaginal, Tablet, chewable - Oral, Insert, extended release, Tablet, chewable, Capsule
Mild to Moderate Acne
0.035 mg, , 0.03 mg, 0.02 mg, 17.4 mg, 0.04 mg, 0.075 mg, 0.025 mg, 0.01 mg, 0.05 mg, 0.085 mg, 0.0015 mg/hour, 0.105 mg, 0.0025 mg, 2.3 mg, 0.6 mg, 0.0035 mg/hour, 0.07 mg, 0.005 mg, 2.7 mg, 2.6 mg, 0.5 mg, 0.75 mg, 0.35 mg, 0.75 mg/[USP'U], 0.0075 mg/hour, 1.0 mg, 0.1 mg
Oral, , Kit; Tablet, coated - Oral, Tablet, Kit; Tablet, chewable - Oral, Kit, Kit - Oral, Kit; Tablet, Kit; Tablet - Oral, Patch, extended release, Tablet - Oral, Kit; Tablet, film coated, Tablet, film coated, Vaginal, Kit; Tablet, film coated - Oral, Kit; Tablet, coated, Kit; Tablet; Tablet, chewable - Oral, Ring - Vaginal, Tablet, film coated - Oral, Kit; Tablet, chewable, Kit; Tablet; Tablet, chewable, Capsule, liquid filled; Kit, Patch - Transdermal, Transdermal, Capsule, liquid filled; Kit - Oral, Patch, extended release - Transdermal, Capsule - Oral, Ring, Patch, Insert, extended release - Vaginal, Tablet, chewable - Oral, Insert, extended release, Tablet, chewable, Capsule
Hormonal Contraception
0.035 mg, , 0.03 mg, 0.02 mg, 17.4 mg, 0.04 mg, 0.075 mg, 0.025 mg, 0.01 mg, 0.05 mg, 0.085 mg, 0.0015 mg/hour, 0.105 mg, 0.0025 mg, 2.3 mg, 0.6 mg, 0.0035 mg/hour, 0.07 mg, 0.005 mg, 2.7 mg, 2.6 mg, 0.5 mg, 0.75 mg, 0.35 mg, 0.75 mg/[USP'U], 0.0075 mg/hour, 1.0 mg, 0.1 mg
Oral, , Kit; Tablet, coated - Oral, Tablet, Kit; Tablet, chewable - Oral, Kit, Kit - Oral, Kit; Tablet, Kit; Tablet - Oral, Patch, extended release, Tablet - Oral, Kit; Tablet, film coated, Tablet, film coated, Vaginal, Kit; Tablet, film coated - Oral, Kit; Tablet, coated, Kit; Tablet; Tablet, chewable - Oral, Ring - Vaginal, Tablet, film coated - Oral, Kit; Tablet, chewable, Kit; Tablet; Tablet, chewable, Capsule, liquid filled; Kit, Patch - Transdermal, Transdermal, Capsule, liquid filled; Kit - Oral, Patch, extended release - Transdermal, Capsule - Oral, Ring, Patch, Insert, extended release - Vaginal, Tablet, chewable - Oral, Insert, extended release, Tablet, chewable, Capsule
Patient desires oral contraception for birth control
0.035 mg, , 0.03 mg, 0.02 mg, 17.4 mg, 0.04 mg, 0.075 mg, 0.025 mg, 0.01 mg, 0.05 mg, 0.085 mg, 0.0015 mg/hour, 0.105 mg, 0.0025 mg, 2.3 mg, 0.6 mg, 0.0035 mg/hour, 0.07 mg, 0.005 mg, 2.7 mg, 2.6 mg, 0.5 mg, 0.75 mg, 0.35 mg, 0.75 mg/[USP'U], 0.0075 mg/hour, 1.0 mg, 0.1 mg
Oral, , Kit; Tablet, coated - Oral, Tablet, Kit; Tablet, chewable - Oral, Kit, Kit - Oral, Kit; Tablet, Kit; Tablet - Oral, Patch, extended release, Tablet - Oral, Kit; Tablet, film coated, Tablet, film coated, Vaginal, Kit; Tablet, film coated - Oral, Kit; Tablet, coated, Kit; Tablet; Tablet, chewable - Oral, Ring - Vaginal, Tablet, film coated - Oral, Kit; Tablet, chewable, Kit; Tablet; Tablet, chewable, Capsule, liquid filled; Kit, Patch - Transdermal, Transdermal, Capsule, liquid filled; Kit - Oral, Patch, extended release - Transdermal, Capsule - Oral, Ring, Patch, Insert, extended release - Vaginal, Tablet, chewable - Oral, Insert, extended release, Tablet, chewable, Capsule
Birth Control
0.035 mg, , 0.03 mg, 0.02 mg, 17.4 mg, 0.04 mg, 0.075 mg, 0.025 mg, 0.01 mg, 0.05 mg, 0.085 mg, 0.0015 mg/hour, 0.105 mg, 0.0025 mg, 2.3 mg, 0.6 mg, 0.0035 mg/hour, 0.07 mg, 0.005 mg, 2.7 mg, 2.6 mg, 0.5 mg, 0.75 mg, 0.35 mg, 0.75 mg/[USP'U], 0.0075 mg/hour, 1.0 mg, 0.1 mg
Oral, , Kit; Tablet, coated - Oral, Tablet, Kit; Tablet, chewable - Oral, Kit, Kit - Oral, Kit; Tablet, Kit; Tablet - Oral, Patch, extended release, Tablet - Oral, Kit; Tablet, film coated, Tablet, film coated, Vaginal, Kit; Tablet, film coated - Oral, Kit; Tablet, coated, Kit; Tablet; Tablet, chewable - Oral, Ring - Vaginal, Tablet, film coated - Oral, Kit; Tablet, chewable, Kit; Tablet; Tablet, chewable, Capsule, liquid filled; Kit, Patch - Transdermal, Transdermal, Capsule, liquid filled; Kit - Oral, Patch, extended release - Transdermal, Capsule - Oral, Ring, Patch, Insert, extended release - Vaginal, Tablet, chewable - Oral, Insert, extended release, Tablet, chewable, Capsule
Folate supplementation therapy
0.035 mg, , 0.03 mg, 0.02 mg, 17.4 mg, 0.04 mg, 0.075 mg, 0.025 mg, 0.01 mg, 0.05 mg, 0.085 mg, 0.0015 mg/hour, 0.105 mg, 0.0025 mg, 2.3 mg, 0.6 mg, 0.0035 mg/hour, 0.07 mg, 0.005 mg, 2.7 mg, 2.6 mg, 0.5 mg, 0.75 mg, 0.35 mg, 0.75 mg/[USP'U], 0.0075 mg/hour, 1.0 mg, 0.1 mg
Oral, , Kit; Tablet, coated - Oral, Tablet, Kit; Tablet, chewable - Oral, Kit, Kit - Oral, Kit; Tablet, Kit; Tablet - Oral, Patch, extended release, Tablet - Oral, Kit; Tablet, film coated, Tablet, film coated, Vaginal, Kit; Tablet, film coated - Oral, Kit; Tablet, coated, Kit; Tablet; Tablet, chewable - Oral, Ring - Vaginal, Tablet, film coated - Oral, Kit; Tablet, chewable, Kit; Tablet; Tablet, chewable, Capsule, liquid filled; Kit, Patch - Transdermal, Transdermal, Capsule, liquid filled; Kit - Oral, Patch, extended release - Transdermal, Capsule - Oral, Ring, Patch, Insert, extended release - Vaginal, Tablet, chewable - Oral, Insert, extended release, Tablet, chewable, Capsule
Premenstrual Dysphoric Disorder
0.035 mg, , 0.03 mg, 0.02 mg, 17.4 mg, 0.04 mg, 0.075 mg, 0.025 mg, 0.01 mg, 0.05 mg, 0.085 mg, 0.0015 mg/hour, 0.105 mg, 0.0025 mg, 2.3 mg, 0.6 mg, 0.0035 mg/hour, 0.07 mg, 0.005 mg, 2.7 mg, 2.6 mg, 0.5 mg, 0.75 mg, 0.35 mg, 0.75 mg/[USP'U], 0.0075 mg/hour, 1.0 mg, 0.1 mg
Oral, , Kit; Tablet, coated - Oral, Tablet, Kit; Tablet, chewable - Oral, Kit, Kit - Oral, Kit; Tablet, Kit; Tablet - Oral, Patch, extended release, Tablet - Oral, Kit; Tablet, film coated, Tablet, film coated, Vaginal, Kit; Tablet, film coated - Oral, Kit; Tablet, coated, Kit; Tablet; Tablet, chewable - Oral, Ring - Vaginal, Tablet, film coated - Oral, Kit; Tablet, chewable, Kit; Tablet; Tablet, chewable, Capsule, liquid filled; Kit, Patch - Transdermal, Transdermal, Capsule, liquid filled; Kit - Oral, Patch, extended release - Transdermal, Capsule - Oral, Ring, Patch, Insert, extended release - Vaginal, Tablet, chewable - Oral, Insert, extended release, Tablet, chewable, Capsule

Warnings

Gildess 1.5/30 Contraindications
Condition
Risk Level
Notes
Coronary Artery Disease
Do Not Combine
Coronary Artery Disease (CAD)
Do Not Combine
Toxoplasma Infections
Do Not Combine
Breast
Do Not Combine
Adrenal Insufficiency
Do Not Combine
Breast Cancer
Do Not Combine
Toxoplasma Infections
Do Not Combine
Thrombophlebitis
Do Not Combine
Breast
Do Not Combine
Toxoplasma Infections
Do Not Combine
Severe Hypertension
Do Not Combine
high risk of venous thrombotic disease
Do Not Combine
Impaired Renal Function
Do Not Combine
Metrorrhagia
Do Not Combine
Deep Vein Thrombosis
Do Not Combine
Thromboembolism
Do Not Combine
undiagnosed abnormal genital bleeding
Do Not Combine
history of deep venous thrombosis
Do Not Combine
Neoplasms, Hepatic
Do Not Combine
Heavy Smoking
Do Not Combine
high risk of arterial thrombotic disease
Do Not Combine
Decompensated Cirrhosis
Do Not Combine
estrogen-sensitive cancer
Do Not Combine
major surgery with prolonged immobilization
Do Not Combine
Hypersensitivity
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Ethinylestradiol may interact with Toxoplasma Infections
There are 20 known major drug interactions with Gildess 1.5/30.
Common Gildess 1.5/30 Drug Interactions
Drug Name
Risk Level
Description
Anastrozole
Major
The therapeutic efficacy of Anastrozole can be decreased when used in combination with Ethinylestradiol.
Astemizole
Major
The metabolism of Astemizole can be decreased when combined with Ethinylestradiol.
Axitinib
Major
The metabolism of Axitinib can be decreased when combined with Ethinylestradiol.
Belinostat
Major
The metabolism of Belinostat can be increased when combined with Ethinylestradiol.
Binimetinib
Major
The metabolism of Binimetinib can be increased when combined with Ethinylestradiol.
Gildess 1.5/30 Toxicity & Overdose RiskWomen who overdose on birth control pills may experience bleeding, nausea, vomiting, breast tenderness, abdominal pain, drowsiness, and fatigue. Treatment for an overdose should include monitoring for electrolyte levels and signs of acidosis, in addition to providing symptomatic and supportive care.

Gildess 1.5/30 Novel Uses: Which Conditions Have a Clinical Trial Featuring Gildess 1.5/30?

There are 38 active studies evaluating the potential of Gildess 1.5/30 to facilitate Folate supplementation therapy, reduce Premenstrual Dysphoric Disorder symptoms and provide relief for Menopausal women.
Condition
Clinical Trials
Trial Phases
Patient desires oral contraception for birth control
0 Actively Recruiting
Premenstrual Dysphoric Disorder
0 Actively Recruiting
Birth Control
35 Actively Recruiting
Phase 4, Not Applicable, Phase 3, Phase 2, Early Phase 1
Hormonal Contraception
0 Actively Recruiting
Menopausal Osteoporosis
0 Actively Recruiting
Acne Vulgaris
0 Actively Recruiting
Mild to Moderate Acne
0 Actively Recruiting
Folate supplementation therapy
0 Actively Recruiting
Menopause
0 Actively Recruiting

Gildess 1.5/30 Reviews: What are patients saying about Gildess 1.5/30?

4Patient Review
10/12/2016
Gildess 1.5/30 for Painful Periods
I was switched to Gildess after Junel was discontinued. I found myself to be very emotional, spacey, and anxious on this new medication. I cried a lot and got frustrated easily. My period was normal and on time, which was good. But I didn't like the other side effects, so I'm hoping to try something else soon.
3Patient Review
4/29/2013
Gildess 1.5/30 for Birth Control
The side effects on this medication are really severe. I've never experienced anything like this with any other birth control, so I'm going back to my old one.
1Patient Review
9/18/2014
Gildess 1.5/30 for Birth Control
Do not take this medication. You will have your period twice a month, and experience bad side effects. I thought maybe it would regulate after 2 months, and the side effects did not stop. This has been a frustrating experience, avoid this medication.
1Patient Review
12/1/2013
Gildess 1.5/30 for Birth Control
In my experience, this treatment made me break out more, caused weight gain, and increased my levels of depression and anxiety. Overall, a terrible experience.
1Patient Review
10/18/2013
Gildess 1.5/30 for Birth Control
I started taking this drug and after only two weeks, I began experiencing serious negative side effects like crying spells, depression, and panic attacks. I had to stop taking the medication and my doctor put me on a different one. In my opinion, Gildess is not worth the risk.

Patient Q&A Section about gildess 1.5/30

Is Microgestin a brand name?

"There are many brand names for this medication. Some examples include Aurovela 1/20, Aurovela 1.5/30, Aurovela 24 Fe, Aurovela Fe 1/20, Aurovela Fe 1.5/30, Blisovi 24 Fe, Blisovi Fe 1/20, Blisovi Fe 1.5/30, Femhrt, Femhrt 1/5, Fyavolv, Estrostep Fe, Hailey 1.5/30, Hailey Fe 1.5/30, Hailey 24 Fe." - Anonymous Online Contributor

Unverified Answer

What is Larin generic for?

"Microgestin 1/20 is a medication that prevents pregnancy in women by combining two drugs, ethinyl estradiol and norethindrone. The generic version of this drug, known as ethinyl estradiol/norethindrone, costs an average of $109 for a supply of 126 tablets." - Anonymous Online Contributor

Unverified Answer

What is Gildess used to treat?

"This hormone medication, which contains a combination of norethindrone (a progestin) and ethinyl estradiol (an estrogen), is used as a means of contraception to prevent pregnancy." - Anonymous Online Contributor

Unverified Answer

What is Gildess Fe?

"This medication helps to prevent ovulation and pregnancy by combining the hormones estrogen and progestin. It may also be used to treat acne." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Clinical Trials for Gildess 1.5/30

Have you considered Gildess 1.5/30 clinical trials? We made a collection of clinical trials featuring Gildess 1.5/30, we think they might fit your search criteria.
Have you considered Gildess 1.5/30 clinical trials? We made a collection of clinical trials featuring Gildess 1.5/30, we think they might fit your search criteria.
Have you considered Gildess 1.5/30 clinical trials? We made a collection of clinical trials featuring Gildess 1.5/30, we think they might fit your search criteria.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top